US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

25.11

+1.395.86%

Volume:2.02M

Turnover:50.25M

Market Cap:2.82B

PE:-24.90

High:25.40

Open:24.00

Low:24.00

Close:23.72

Loading ...

Overview Company News Filings

Cautious Hold Rating for Viking Therapeutics Amid Competitive Obesity Market Challenges

NVO & LLY Shares Down on Exclusion of Obesity Drugs From Medicare

Viking Therapeutics Director Makes a Bold Stock Purchase!

Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now?

Analysts Conflicted on These Healthcare Names: Zentalis Pharmaceuticals (ZNTL) and Viking Therapeutics (VKTX)

VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug

Viking Therapeutics Price Target Maintained With a $102.00/Share by HC Wainwright & Co.

Viking Therapeutics’ Strategic Advancements and Promising VK2735 Trial Support Buy Rating

Positive Outlook for Viking Therapeutics: Strong Trial Enrollment and Upcoming Milestones Suggest Upside Potential

Viking Therapeutics Inc: Expects to Report Data From Study in Second Half of 2025.

THOMSON REUTERS

Viking Therapeutics Announces Completion of Enrollment in Phase 2 Venture-Oral Dosing Trial of Vk2735 Tablet Formulation in Patients With Obesity

THOMSON REUTERS

Viking Therapeutics Announces Completion of Enrollment in Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity

Viking Therapeutics, Inc. (VKTX) Rises But Trails Market: What Investors Should Know

Viking Therapeutics (NasdaqCM:VKTX) Soars 10% With CordenPharma Manufacturing Agreement

Simply Wall St.

What might happen next after the S&P 500's correction?

An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup

NVO Stock Slips 4% as Roche Inks Obesity Drug Deal With Zealand

Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue?

How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma

B. Riley sees two key positives in Viking manufacturing agreement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VKTX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VKTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VKTX\",,,,,undefined,":{"symbol":"VKTX","market":"US","secType":"STK","nameCN":"Viking Therapeutics","latestPrice":25.11,"timestamp":1745345079172,"preClose":23.72,"halted":0,"volume":2024623,"delay":0,"floatShares":109743358,"shares":112247809,"eps":-1.008491,"marketStatus":"Trading","change":1.39,"latestTime":"04-22 14:04:49 EDT","open":24,"high":25.4,"low":24,"amount":50252884.03578,"amplitude":0.059022,"askPrice":25.12,"askSize":263,"bidPrice":25.07,"bidSize":195,"shortable":3,"etf":0,"ttmEps":-1.008491,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1430280000000,"exchange":"NASDAQ","adjPreClose":23.72,"preHourTrading":{"tag":"盘前","latestPrice":24.06,"preClose":23.72,"latestTime":"09:29 EDT","volume":11584,"amount":278770.75552,"timestamp":1745328599999},"postHourTrading":{"tag":"盘后","latestPrice":23.65,"preClose":23.72,"latestTime":"19:51 EDT","volume":10987,"amount":260460.3331,"timestamp":1745279509128},"volumeRatio":0.594419,"optionData":{"bulkOrders":[{"symbol":"VKTX","call":false,"expireDate":1755230400000,"strike":"22.5","timestamp":1745335929308,"price":3.8,"volume":5000,"amount":1900000,"type":"+"}]},"impliedVol":0.9345,"impliedVolPercentile":0.564},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VKTX\",,,,,undefined,":{"symbol":"VKTX","floatShares":109743358,"roa":"-14.78%","roe":"-17.90%","lyrEps":-1.008491,"volumeRatio":0.594419,"shares":112247809,"dividePrice":0,"high":25.4,"amplitude":0.059022,"preClose":23.72,"low":24,"week52Low":18.92,"pbRate":"3.20","week52High":81.86,"institutionHeld":0,"latestPrice":25.11,"committee":-0.148472,"eps":-1.008491,"divideRate":0,"volume":2024623,"delay":0,"ttmEps":-1.008491,"open":24,"prevYearClose":40.24,"prevWeekClose":23.94,"prevMonthClose":24.15,"prevQuarterClose":24.15,"fiveDayClose":24.57,"twentyDayClose":29.28,"sixtyDayClose":34.5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VKTX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2525837003","title":"Cautious Hold Rating for Viking Therapeutics Amid Competitive Obesity Market Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2525837003","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525837003?lang=en_us&edition=fundamental","pubTime":"2025-04-08 14:45","pubTimestamp":1744094712,"startTime":"0","endTime":"0","summary":"Richard Law CFA, an analyst from Goldman Sachs, maintained the Hold rating on Viking Therapeutics (VKTX – Research Report). The associated price ta...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/cautious-hold-rating-for-viking-therapeutics-amid-competitive-obesity-market-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/cautious-hold-rating-for-viking-therapeutics-amid-competitive-obesity-market-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VKTX"],"gpt_icon":0},{"id":"2525200040","title":"NVO & LLY Shares Down on Exclusion of Obesity Drugs From Medicare","url":"https://stock-news.laohu8.com/highlight/detail?id=2525200040","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525200040?lang=en_us&edition=fundamental","pubTime":"2025-04-07 21:14","pubTimestamp":1744031640,"startTime":"0","endTime":"0","summary":"On Friday, The Centers for Medicare & Medicaid Services  did not finalize a provision to cover obesity drugs like Eli Lilly's LLY and Novo Nordisk’s NVO popular injections, Zepbound and Wegovy, respectively, under its Part D prescription drug coverage. In other words, Medicare will not pay for the cost of these expensive weight-loss medicines.At present, Medicare does not cover Zepbound and Wegovy if they are solely prescribed for weight loss. However, CMS may consider these proposals at a later date.In response, shares of Eli Lilly and Novo Nordisk declined 6.5% and 6.8%, respectively, on Friday.Year to date, while LLY’s stock has declined 4.2%, Novo Nordisk’s stock has plunged 26.4% compared with the industry’s decrease of 4.8%. However, Robert F. Kennedy Jr., the new head of Health and Human Services, has been skeptical about obesity drugs and has advocated exercise and a healthy diet to manage obesity and type II diabetes.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nvo-lly-shares-down-exclusion-131400783.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SG9999014914.USD","LU0114720955.EUR","NVO","LU0320765992.SGD","LU0672654240.SGD","LU1023059063.AUD","LU2491049909.HKD","LU0471298777.SGD","LU1548497426.USD","LU0823416689.USD","IE00BFTCPJ56.SGD","LU1127390331.HKD","LU0820561818.USD","GB00BDT5M118.USD","LU2491050071.SGD","SGXZ99366536.SGD","LU1804176565.USD","LU1814569148.SGD","LU1917777945.USD","BK4139","LU0203202063.USD","BK4585","LU0203201768.USD","LU1551013342.USD","LU0354030511.USD","LLY","SG9999015986.USD","LU0882574055.USD","BK4533","SG9999014898.SGD","LU1057294990.SGD","SG9999018857.SGD","LU1868837136.USD","LU2237438978.USD","LU1093756168.USD","LU0889565916.HKD","LU1989771016.USD","SG9999014906.USD","LU2461242641.AUD","LU2552382132.HKD","LU0109394709.USD","LU0061475181.USD","VKTX","LU2063271972.USD","AMGN","LU0456855351.SGD","LU2237443895.HKD","CMS","BK4588","LU2552382058.USD"],"gpt_icon":1},{"id":"2524747669","title":"Viking Therapeutics Director Makes a Bold Stock Purchase!","url":"https://stock-news.laohu8.com/highlight/detail?id=2524747669","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524747669?lang=en_us&edition=fundamental","pubTime":"2025-04-03 10:02","pubTimestamp":1743645742,"startTime":"0","endTime":"0","summary":"New insider activity at Viking Therapeutics ( ($VKTX) ) has taken place on April 3, 2025. Director Sarah Kathryn Rouan has made a significant inves...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/viking-therapeutics-director-makes-a-bold-stock-purchase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/viking-therapeutics-director-makes-a-bold-stock-purchase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","VKTX","BK4599","BK4585","BK4588"],"gpt_icon":0},{"id":"2524430080","title":"Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524430080","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524430080?lang=en_us&edition=fundamental","pubTime":"2025-04-02 16:40","pubTimestamp":1743583200,"startTime":"0","endTime":"0","summary":"Viking soared more than 100% in one trading session last year on positive clinical trial news.Viking's candidate falls into this category of drugs, so it works in the same way as its earlier-to-market rivals. It's difficult to compare the candidates head to head, since we're talking about one involved in clinical trials with certain parameters versus treatments that are out in the marketplace.But Viking's trial results have been strong so far. For example, the injectable VK2735 in a phase 2 trial met primary and secondary endpoints, and participants saw a reduction in mean body weight of as much as 14.7% after 13 weeks of dosing. And a phase 1 trial of the oral version produced weight loss o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/04/02/viking-therapeutics-down-40-reached-milestone/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4599","VKTX","BK4585","BK4588","BK4139"],"gpt_icon":1},{"id":"2523961204","title":"Analysts Conflicted on These Healthcare Names: Zentalis Pharmaceuticals (ZNTL) and Viking Therapeutics (VKTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2523961204","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523961204?lang=en_us&edition=fundamental","pubTime":"2025-03-31 15:00","pubTimestamp":1743404437,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Zentalis Pharmaceuticals (ZNTL – Research Report) ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-zentalis-pharmaceuticals-zntl-and-viking-therapeutics-vktx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-zentalis-pharmaceuticals-zntl-and-viking-therapeutics-vktx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZNTL","BK4588","HCSG","VKTX","BK4599","BK4139","BK4137","BK4585"],"gpt_icon":0},{"id":"2522309020","title":"VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2522309020","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522309020?lang=en_us&edition=fundamental","pubTime":"2025-03-27 20:31","pubTimestamp":1743078660,"startTime":"0","endTime":"0","summary":"Viking Therapeutics VKTX announced that it has completed enrolling study participants in the phase II VENTURE-Oral Dosing study, which is evaluating the safety and efficacy of the oral formulation of its experimental obesity drug VK2735. Data from this study is expected in the second half of 2025.This study has enrolled around 280 adults who are either obese or overweight and have at least one weight-related co-morbid condition. These patients have been evenly randomized to one of the six dosing arms of the drug or placebo. The study’s primary endpoint is the percent change in body weight from baseline after 13 weeks of treatment.In our opinion, this announcement marks a milestone for the company since the study initiation was declared in January. The rapid enrolment in the study suggests strong demand and interest in VK2735. This aligns with the market expansion for weight loss drugs, fueled by the success of Eli Lilly’s LLY Zepbound and Novo Nordisk’s NVO Wegovy. The quick recruitmen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vktx-finishes-enrolment-mid-stage-123100379.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LU1037948541.HKD","AMGN","LU0965509283.SGD","LU2491050154.USD","LU2602419157.SGD","SG9999013999.USD","SGXZ81514606.USD","LU1127390331.HKD","VKTX","LU0198837287.USD","LU0689472784.USD","LU1988902786.USD","LU0823416689.USD","LU1280957306.USD","IE00B42XCP33.USD","LU0820561818.USD","LU2129689605.HKD","03165","SG9999018865.SGD","SSI","IE00BFTCPJ56.SGD","IE00BK4W5L77.USD","BK4532","LU0109391861.USD","BK4533","LU1023059063.AUD","SG9999011175.SGD","LU1974910355.USD","ABBV","LU0882574139.USD","LU0122379950.USD","LU1551013425.SGD","LU0094547139.USD","LU2087621335.USD","LLY","LU1064131342.USD","SG9999014898.SGD","SG9999018857.SGD","IE00BVYPNW00.USD","LU1003077747.HKD","LU0965509101.SGD","LU0310800379.SGD","LU0006306889.USD","LU1720051017.SGD","LU1732800096.USD","LU0661504455.SGD","SGXZ57979304.SGD","IE00B19Z3581.USD","RHHBY"],"gpt_icon":1},{"id":"2522338413","title":"Viking Therapeutics Price Target Maintained With a $102.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2522338413","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522338413?lang=en_us&edition=fundamental","pubTime":"2025-03-26 23:51","pubTimestamp":1743004260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VKTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 26, 2025 11:51 ET (15:51 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VKTX"],"gpt_icon":0},{"id":"2522802804","title":"Viking Therapeutics’ Strategic Advancements and Promising VK2735 Trial Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2522802804","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522802804?lang=en_us&edition=fundamental","pubTime":"2025-03-26 21:35","pubTimestamp":1742996110,"startTime":"0","endTime":"0","summary":"Analyst Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report) and keeping the price target ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/viking-therapeutics-strategic-advancements-and-promising-vk2735-trial-support-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/viking-therapeutics-strategic-advancements-and-promising-vk2735-trial-support-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VKTX"],"gpt_icon":0},{"id":"2522849804","title":"Positive Outlook for Viking Therapeutics: Strong Trial Enrollment and Upcoming Milestones Suggest Upside Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2522849804","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522849804?lang=en_us&edition=fundamental","pubTime":"2025-03-26 21:27","pubTimestamp":1742995638,"startTime":"0","endTime":"0","summary":"William Blair analyst Andy Hsieh has maintained their bullish stance on VKTX stock, giving a Buy rating on March 12. Andy Hsieh has given his Buy r...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/positive-outlook-for-viking-therapeutics-strong-trial-enrollment-and-upcoming-milestones-suggest-upside-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/positive-outlook-for-viking-therapeutics-strong-trial-enrollment-and-upcoming-milestones-suggest-upside-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4139","BK4599","BK4588","VKTX"],"gpt_icon":0},{"id":"2522878834","title":"Viking Therapeutics Inc: Expects to Report Data From Study in Second Half of 2025.","url":"https://stock-news.laohu8.com/highlight/detail?id=2522878834","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522878834?lang=en_us&edition=fundamental","pubTime":"2025-03-26 19:05","pubTimestamp":1742987103,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nTUA4BK1LM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VKTX","BK4139","BK4588","BK4585","BK4599"],"gpt_icon":0},{"id":"2522788808","title":"Viking Therapeutics Announces Completion of Enrollment in Phase 2 Venture-Oral Dosing Trial of Vk2735 Tablet Formulation in Patients With Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2522788808","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522788808?lang=en_us&edition=fundamental","pubTime":"2025-03-26 19:05","pubTimestamp":1742987103,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nTUA4BK1LM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4599","VKTX","BK4585","BK4588","BK4139"],"gpt_icon":0},{"id":"2522875637","title":"Viking Therapeutics Announces Completion of Enrollment in Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2522875637","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522875637?lang=en_us&edition=fundamental","pubTime":"2025-03-26 19:05","pubTimestamp":1742987100,"startTime":"0","endTime":"0","summary":"13-Week Study Evaluating the Safety and Efficacy of Oral VK2735 Dosed Once Daily. SAN DIEGO, March 26, 2025 /PRNewswire/ --Viking Therapeutics, Inc.  , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the completion of subject enrollment in its Phase 2 clinical trial of the oral tablet formulation of VK2735, the company's dual agonist of the glucagon-like peptide 1  and glucose-dependent insulinotropic polypeptide  receptors. VK2375 is being developed in both oral and subcutaneous formulations for the potential treatment of various metabolic disorders such as obesity. Viking expects to report data from the study in the second half of 2025.\"As with our previous Phase 2 study of subcutaneous VK2735, interest in participating in the Phase 2 VENTURE-Oral study was high and drove an efficient rate of enrollment,\" said Brian Lian, Ph.D., chief executive officer of Viking Therapeutics. \"Despite its ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/viking-therapeutics-announces-completion-enrollment-110500407.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/viking-therapeutics-announces-completion-enrollment-110500407.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4599","BK4139","AMN","BK4585","BK4588","VKTX","BK4196"],"gpt_icon":0},{"id":"2522227084","title":"Viking Therapeutics, Inc. (VKTX) Rises But Trails Market: What Investors Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2522227084","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522227084?lang=en_us&edition=fundamental","pubTime":"2025-03-25 05:45","pubTimestamp":1742852717,"startTime":"0","endTime":"0","summary":"The most recent trading session ended with Viking Therapeutics, Inc.  standing at $29.28, reflecting a +1.14% shift from the previouse trading day's closing. The stock's change was less than the S&P 500's daily gain of 1.77%. Elsewhere, the Dow saw an upswing of 1.42%, while the tech-heavy Nasdaq appreciated by 2.28%.The the stock of company has fallen by 15.03% in the past month, lagging the Medical sector's loss of 1.17% and the S&P 500's loss of 5.73%.Analysts and investors alike will be keeping a close eye on the performance of Viking Therapeutics, Inc. in its upcoming earnings disclosure. In that report, analysts expect Viking Therapeutics, Inc. to post earnings of -$0.34 per share. This would mark a year-over-year decline of 30.77%.Any recent changes to analyst estimates for Viking Therapeutics, Inc. should also be noted by investors. These revisions typically reflect the latest short-term business trends, which can change frequently. Hence, positive alterations in estimates sign","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/viking-therapeutics-inc-vktx-rises-214517209.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4211","ISBC","BK4585","BK4599","BK4139","VKTX"],"gpt_icon":1},{"id":"2520506936","title":"Viking Therapeutics (NasdaqCM:VKTX) Soars 10% With CordenPharma Manufacturing Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2520506936","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520506936?lang=en_us&edition=fundamental","pubTime":"2025-03-18 01:33","pubTimestamp":1742232805,"startTime":"0","endTime":"0","summary":"Viking Therapeutics experienced a share price increase of 10% last week, coinciding with the announcement of a multi-year manufacturing agreement with CordenPharma for its V2735 program targeting obesity. This agreement is a strategic move enhancing the company’s ability to secure a position within the potentially lucrative obesity treatment market. The market backdrop has been characterized by mixed performance, with major indexes like the Dow and Nasdaq experiencing fluctuations amid economic uncertainties and tech sell-offs. Despite this, Viking's shares stood out, likely buoyed by the positive sentiment surrounding the manufacturing deal. While broader market sentiment was affected by the tech sector's struggles and economic policy concerns, the developments for Viking's business expansion appear to have contributed positively to its stock performance in an otherwise challenging market context.Assess the potential risks impacting Viking Therapeutics' growth trajectory—explore our r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/viking-therapeutics-nasdaqcm-vktx-soars-173325462.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Viking Therapeutics (NasdaqCM:VKTX) Soars 10% With CordenPharma Manufacturing Agreement","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VKTX","BK4139","BK4588","BK4585","BK4599"],"gpt_icon":1},{"id":"2519212381","title":"What might happen next after the S&P 500's correction?","url":"https://stock-news.laohu8.com/highlight/detail?id=2519212381","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519212381?lang=en_us&edition=fundamental","pubTime":"2025-03-14 23:53","pubTimestamp":1741967580,"startTime":"0","endTime":"0","summary":"A correction for a stock index is typically defined as a decline of at least 10% from a recent high, while a bear market is a decline of at least 20%. The S&P 500 SPX slipped into correction territory on Thursday, when the index declined 1.4%, for a 10.1% pullback from its most recent closing high on Feb. 19.Here is how the 11 sectors of the S&P 500 have performed this year and for longer periods through Thursday, with dividends reinvested. The table is sorted by this year's price returns, ascending, with the full index at the bottom.Sector or index           2025 return  2024 return  2023 return  2022 return  Return since end of 2021. Joseph Adinolfi dug into technical factors and described six charts for investors to watch following the S&P 500's decline.Early on Friday, Mark Hulbert shared an analysis indicating that the worst of the market decline may be over and looking at how quickly the S&P 500 might be ex","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SDS","SPY","TSYW.SI","3NVD.UK","LU2237443549.SGD","LU1934455194.USD",".SPX","LUV","LU0171293334.USD","NVD2.UK","IE0004445015.USD","LU1629891620.HKD","NVDS.UK","NVIW.SI","BK4574","TSLL","OEF","SPXU","LU0096362180.USD","SSO","DECK","LU2237443622.USD","SNVD.UK","LU1551013425.SGD","NVDS","NVD3.UK","2NVD.UK","NVDU","LU0960925559.SGD","SH","VKTX","LU0965509101.SGD","ESmain","VOO","IVV","NVDD","OEX","NVDY","LU2361044865.SGD","BK4614"],"gpt_icon":1},{"id":"2519873483","title":"An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2519873483","media":"Quartz","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519873483?lang=en_us&edition=fundamental","pubTime":"2025-03-14 17:00","pubTimestamp":1741942800,"startTime":"0","endTime":"0","summary":"Graphic: Images: Hims & Hers, Andrew Harnik, Spencer Platt / Staff, Stephen Maturen / Stringer. An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as it would be easier to manufacture and distribute globally. Three U.S. senators have demanded, in a letter, that Health and Human Services  Secretary Robert F. Kennedy Jr. share details about several private dinners he attended with Donald Trump and healthcare executives at Mar-a-Lago. Novo Nordisk released clinical trial results on Monday for its potential Ozempic successor, but for the second time, it fell short of analysts’ expectations, disappointing Wall Street.Check out those stories and more pharmaceutical news highlights from this week.Hims & Hers, Zealand, and Roche fall: Why weight loss drug stocks are down today. Hims & Hers will start selling generic liraglutide later this year. - Image: Hims & Hers ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ozempic-successor-falls-short-eli-090000158.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","LLY","LU2028103732.USD","LU0158827948.USD","LU1061106388.HKD","LU0354030438.USD","CVS","API","LU2063271972.USD","03165","WBA","LU0321505439.SGD","LU1093756168.USD","LU0385154629.USD","LU1868837136.USD","LU2089283258.USD","IE00BJJMRZ35.SGD","LU0208291251.USD","LU1267930730.SGD","LU2265009873.SGD","LU1623119135.USD","LU1059921491.USD","LU2023250504.SGD","LU0256863811.USD","NVO","LU0154236417.USD","BK4009","LU0672654240.SGD","LU1917777945.USD","BK4144","LU0320765646.SGD","GLP","LU1989772840.SGD","LU2357305700.SGD","VKTX","LU1548497426.USD","LU0354030511.USD","LU1074936037.SGD","SG9999001176.USD","LU2602419157.SGD","RHHBY","HHS","SG9999014880.SGD","IE00BFTCPJ56.SGD","SGXZ51526630.SGD","LU2361044865.SGD","SG9999014898.SGD","LU0225283273.USD","LU2023251221.USD"],"gpt_icon":1},{"id":"2519863829","title":"NVO Stock Slips 4% as Roche Inks Obesity Drug Deal With Zealand","url":"https://stock-news.laohu8.com/highlight/detail?id=2519863829","media":"Zacks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519863829?lang=en_us&edition=fundamental","pubTime":"2025-03-14 01:23","pubTimestamp":1741886580,"startTime":"0","endTime":"0","summary":"Novo Nordisk’s NVO stock declined 4.3% on Wednesday after Roche RHHBY announced a license and collaboration deal worth $5.3 billion with Denmark’s Zealand Pharma to co-develop its lead obesity candidate petrelintide. Roche’s latest deal increases competition in the obesity space.Roche Buys Rights to Obesity Drug From Zealand Pharma. Amylin drugs work similarly to the popular GLP-1 drugs ruling the obesity space. The GLP-1 space is dominated by NVO and Eli Lilly LLY, with their popular obesity injections, Wegovy  and Zepbound , respectively. Like GLP-1 drugs mimica naturally occurring hormone, GLP-1, to regulate blood sugar and promote weight loss, amylin drugs mimic another natural hormone amylin, which is secreted at the same time as insulin in response to food intake. Amylin drugs are being considered the next generation of obesity medicines after the current GLP-1 medicines.NVO’s stock has plunged 44.4% in the past year compared with a decrease of 5.2% for the industry.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nvo-stock-slips-4-roche-172300319.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0256863902.USD","LU0385154629.USD","03165","VKTX","SG9999001176.USD","LU2106854487.HKD","BK4581","LU0820561818.USD","LU2112291526.USD","IE00BJLML261.HKD","LU1814569148.SGD","LU1127390331.HKD","LU2237443549.SGD","LU0882574139.USD","LU0061475181.USD","LU2324357040.USD","LU2264538146.SGD","LU1548497426.USD","NVO","LU2237443622.USD","SG9999014898.SGD","SGXZ51526630.SGD","BK4599","LU1093756168.USD","IE00B4R5TH58.HKD","LU1291159041.SGD","LU1551013425.SGD","IE00BK4W5M84.HKD","LU2491049909.HKD","LU1868837136.USD","LU2023250504.SGD","LU2237443465.HKD","LU2360106947.USD","SG9999017495.SGD","LU2602419157.SGD","LU1720051108.HKD","SG9999015945.SGD","LU2491050154.USD","RHHBY","LU2089984988.USD","BK4007","SG9999018865.SGD","LU0058720904.USD","SG9999015986.USD","LU0466842654.USD","ZLDPF","LU0417517546.SGD","CDMO","LU1069344957.HKD"],"gpt_icon":1},{"id":"2519857047","title":"Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue?","url":"https://stock-news.laohu8.com/highlight/detail?id=2519857047","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519857047?lang=en_us&edition=fundamental","pubTime":"2025-03-13 23:30","pubTimestamp":1741879831,"startTime":"0","endTime":"0","summary":"A month has gone by since the last earnings report for Sage Therapeutics, Inc. . Shares have added about 7.4% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Sage Therapeutics due for a pullback?Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.It turns out, fresh estimates flatlined during the past month.The consensus estimate has shifted 13.67% due to these changes.Sage Therapeutics is part of the Zacks Medical - Biomedical and Genetics industry. Over the past month, Viking Therapeutics, Inc. , a stock from the same industry, has gained 0.8%. The company reported its results for the quarter ended December 2024 more than a month ago.Viking Therapeutics reported revenues of $0 million in the last reported quarter, representing a year-over-year change of. Viking The","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sage-therapeutics-sage-7-4-153031603.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SAGE","VKTX"],"gpt_icon":0},{"id":"2519597648","title":"How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2519597648","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519597648?lang=en_us&edition=fundamental","pubTime":"2025-03-13 22:21","pubTimestamp":1741875660,"startTime":"0","endTime":"0","summary":"Shares of Viking Therapeutics VKTX gained more than 11% on Wednesday after the company announced that it had signed a broad multi-year manufacturing agreement with CordenPharma for both the oral and subcutaneous  formulations of its obesity drug.Viking Therapeutics is one of the few biotech stocks that has shown immense potential in the obesity space. It is developing VK2735, an investigational novel dual GLP-1 and GIP receptor agonist, in different clinical studies as oral and SC versions for treating obesity.Per the terms, CordenPharma will provide 100 million autoinjectors, 100 million vial and syringe products, and more than 1 billion oral VK2735 tablets annually through dedicated manufacturing lines. In addition, VKTX will retain an option to expand these capacities. In return, the company will make prepayments totaling $150 million over the next three years, which will be adjusted against future orders.Taking a page from Lilly/Novo’s book, Viking Therapeutics is not limiting itse","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/play-vktx-stock-amid-manufacturing-142100412.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0471298694.HKD","IE00BZ1G4Q59.USD","LU1280957306.USD","LU0471298777.SGD","NVO","LU1720051017.SGD","SGXZ51526630.SGD","IE0004445239.USD","LU0203202063.USD","LU0154236417.USD","LU1974910355.USD","LU1868836914.USD","LU2237443382.USD","LU0289739699.SGD","BK4588","LU0820561909.HKD","LU2106854487.HKD","LU0203201768.USD","LU1057294990.SGD","IE00BJT1NW94.SGD","BK4585","LU0943347566.SGD","LU1868837300.USD","BK4581","IE00BFTCPJ56.SGD","LU0708995401.HKD","LU0820561818.USD","SG9999015986.USD","LU0061475181.USD","LU2265009873.SGD","LU1989771016.USD","LU1061106388.HKD","LU0320765059.SGD","SG9999014880.SGD","LLY","LU1868836591.USD","LU0640476718.USD","LU2237438978.USD","VKTX","LU2237443549.SGD","LU0882574139.USD","LU2264538146.SGD","LU0823416689.USD","LU2023250504.SGD","LU1868837136.USD","LU1093756325.SGD","LU2237443978.SGD","SGXZ57979304.SGD","LU2237443622.USD","LU1868836757.USD"],"gpt_icon":1},{"id":"2518472645","title":"B. Riley sees two key positives in Viking manufacturing agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2518472645","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518472645?lang=en_us&edition=fundamental","pubTime":"2025-03-11 23:35","pubTimestamp":1741707312,"startTime":"0","endTime":"0","summary":"B. Riley analyst Mayank Mamtani reiterates a Buy rating on Viking Therapeutics (VKTX) with a $96 price target after the company announced a “long-a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/b-riley-sees-two-key-positives-in-viking-manufacturing-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/b-riley-sees-two-key-positives-in-viking-manufacturing-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z4B17.USD","BK4127","IE00B7SZL793.SGD","RILY","VKTX","BK4139","BK4599","IE00B66KJ199.SGD","BK4585","IE0031619046.USD","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VKTX\",params:#limit:5,,,undefined,":[{"date":"2025-04-23","symbol":"VKTX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.34,"defaultRemindTime":1745438400000,"name":null,"time":"Post Market","dateTimestamp":1745380800000,"actualEps":null},{"market":"US","date":"2025-02-05","symbol":"VKTX","fiscalQuarterEnding":"2024/12","expectedEps":-0.27,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1738731600000,"reportTimeType":"post","actualEps":-0.32},{"market":"US","date":"2024-10-23","symbol":"VKTX","fiscalQuarterEnding":"2024/09","expectedEps":-0.24,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1729656000000,"reportTimeType":"post","actualEps":-0.22},{"market":"US","date":"2024-07-24","symbol":"VKTX","fiscalQuarterEnding":"2024/06","expectedEps":-0.26,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1721793600000,"reportTimeType":"post","actualEps":-0.2},{"market":"US","date":"2024-04-24","symbol":"VKTX","fiscalQuarterEnding":"2024/03","expectedEps":-0.27,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1713931200000,"reportTimeType":"post","actualEps":-0.26}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VKTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VKTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.5,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":18,"updateTime":1744344000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VKTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VKTX","date":"2025-04-21","current":-24.437425,"percent":0.283279,"low":-119.243765,"twenty":-31.80442,"median":-13.537772,"eighty":-6.973421,"high":-2.86002,"avg":-23.751022,"sd":24.088061,"marketCap":2687212547},"quantilePoints":[{"date":"2020-04-24","current":-16.916979,"twenty":-28.408951,"median":-10.19753,"eighty":-1.409397,"marketCap":436102806},{"date":"2020-05-01","current":-12.954313,"twenty":-28.217552,"median":-10.222281,"eighty":-1.409943,"marketCap":395650641},{"date":"2020-05-08","current":-15.497637,"twenty":-28.073994,"median":-10.222281,"eighty":-1.409943,"marketCap":473328840},{"date":"2020-05-15","current":-16.876262,"twenty":-27.752939,"median":-10.222281,"eighty":-1.409943,"marketCap":515434780},{"date":"2020-05-22","current":-18.896659,"twenty":-27.520316,"median":-10.222281,"eighty":-1.409943,"marketCap":577141761},{"date":"2020-05-29","current":-16.995108,"twenty":-27.38396,"median":-10.222281,"eighty":-1.409943,"marketCap":519064603},{"date":"2020-06-05","current":-17.541804,"twenty":-27.29474,"median":-10.222281,"eighty":-1.409943,"marketCap":535761786},{"date":"2020-06-12","current":-17.232802,"twenty":-27.041821,"median":-10.222281,"eighty":-1.409943,"marketCap":526324248},{"date":"2020-06-19","current":-18.005307,"twenty":-26.888087,"median":-10.222281,"eighty":-1.409943,"marketCap":549918093},{"date":"2020-06-26","current":-17.969653,"twenty":-26.598239,"median":-10.222281,"eighty":-1.409943,"marketCap":548829146},{"date":"2020-07-02","current":-15.877947,"twenty":-26.369161,"median":-10.222281,"eighty":-1.409943,"marketCap":484944272},{"date":"2020-07-10","current":-16.186949,"twenty":-26.115599,"median":-10.222281,"eighty":-1.409943,"marketCap":494381810},{"date":"2020-07-17","current":-16.876262,"twenty":-25.931073,"median":-10.222281,"eighty":-1.409943,"marketCap":515434780},{"date":"2020-07-24","current":-16.044333,"twenty":-25.759126,"median":-10.222281,"eighty":-1.409943,"marketCap":490026024},{"date":"2020-07-31","current":-15.744869,"twenty":-25.659974,"median":-10.222281,"eighty":-1.409943,"marketCap":510763560},{"date":"2020-08-07","current":-16.888727,"twenty":-25.571396,"median":-10.222281,"eighty":-1.409943,"marketCap":547870315},{"date":"2020-08-14","current":-16.507441,"twenty":-25.399289,"median":-10.222281,"eighty":-1.409943,"marketCap":535501397},{"date":"2020-08-21","current":-17.785871,"twenty":-25.399289,"median":-10.482169,"eighty":-1.409943,"marketCap":576973652},{"date":"2020-08-28","current":-15.318726,"twenty":-25.399289,"median":-10.862146,"eighty":-1.409943,"marketCap":496939475},{"date":"2020-09-04","current":-13.726296,"twenty":-25.399289,"median":-11.2704,"eighty":-1.409943,"marketCap":445281053},{"date":"2020-09-11","current":-12.851581,"twenty":-25.399289,"median":-11.467303,"eighty":-1.409943,"marketCap":416905299},{"date":"2020-09-18","current":-15.341155,"twenty":-25.399289,"median":-11.849701,"eighty":-1.409943,"marketCap":497667059},{"date":"2020-09-25","current":-13.524439,"twenty":-25.399289,"median":-12.144044,"eighty":-1.409943,"marketCap":438732802},{"date":"2020-10-02","current":-12.447867,"twenty":-25.399289,"median":-12.388496,"eighty":-1.409943,"marketCap":403808798},{"date":"2020-10-09","current":-13.726296,"twenty":-25.399289,"median":-12.482803,"eighty":-1.409943,"marketCap":445281053},{"date":"2020-10-16","current":-13.232867,"twenty":-25.399289,"median":-12.79011,"eighty":-1.409943,"marketCap":429274217},{"date":"2020-10-23","current":-12.829153,"twenty":-25.399289,"median":-12.840367,"eighty":-1.409943,"marketCap":416177716},{"date":"2020-10-30","current":-11.409829,"twenty":-25.399289,"median":-12.840367,"eighty":-1.409943,"marketCap":410719602},{"date":"2020-11-06","current":-12.261006,"twenty":-25.399289,"median":-12.840367,"eighty":-1.409943,"marketCap":441359430},{"date":"2020-11-13","current":-12.34207,"twenty":-25.399289,"median":-12.840367,"eighty":-1.409943,"marketCap":444277509},{"date":"2020-11-20","current":-12.787925,"twenty":-25.399289,"median":-12.851581,"eighty":-1.409943,"marketCap":460326943},{"date":"2020-11-27","current":-13.537772,"twenty":-25.399289,"median":-12.879123,"eighty":-1.410746,"marketCap":487319172},{"date":"2020-12-04","current":-12.828457,"twenty":-25.399289,"median":-12.921785,"eighty":-1.415684,"marketCap":461785982},{"date":"2020-12-11","current":-12.747393,"twenty":-25.399289,"median":-12.921785,"eighty":-1.417603,"marketCap":458867903},{"date":"2020-12-18","current":-13.010853,"twenty":-25.399289,"median":-13.042279,"eighty":-1.417603,"marketCap":468351660},{"date":"2020-12-24","current":-12.564998,"twenty":-25.399289,"median":-13.042279,"eighty":-1.42011,"marketCap":452302226},{"date":"2020-12-31","current":-11.409829,"twenty":-25.399289,"median":-13.042279,"eighty":-1.420969,"marketCap":410719602},{"date":"2021-01-08","current":-13.456707,"twenty":-25.399289,"median":-13.071141,"eighty":-1.430842,"marketCap":484401094},{"date":"2021-01-15","current":-13.132449,"twenty":-25.399289,"median":-13.137801,"eighty":-1.432871,"marketCap":472728778},{"date":"2021-01-22","current":-13.821498,"twenty":-25.399289,"median":-13.178407,"eighty":-1.441415,"marketCap":497532449},{"date":"2021-01-29","current":-14.814538,"twenty":-25.399289,"median":-13.255296,"eighty":-1.443614,"marketCap":533278915},{"date":"2021-02-05","current":-19.597343,"twenty":-25.399289,"median":-13.349423,"eighty":-1.450892,"marketCap":705445569},{"date":"2021-02-12","current":-17.003279,"twenty":-25.399289,"median":-13.476973,"eighty":-1.4635,"marketCap":612067045},{"date":"2021-02-19","current":-14.396785,"twenty":-25.399289,"median":-13.536713,"eighty":-1.490029,"marketCap":568601038},{"date":"2021-02-26","current":-12.651152,"twenty":-25.399289,"median":-13.536713,"eighty":-1.520167,"marketCap":499657235},{"date":"2021-03-05","current":-12.482219,"twenty":-25.411586,"median":-13.537772,"eighty":-1.598396,"marketCap":492985254},{"date":"2021-03-12","current":-12.669922,"twenty":-25.411586,"median":-13.537772,"eighty":-1.619034,"marketCap":500398566},{"date":"2021-03-19","current":-11.80649,"twenty":-25.411586,"median":-13.537772,"eighty":-1.632817,"marketCap":466297331},{"date":"2021-03-26","current":-11.637558,"twenty":-25.399289,"median":-13.536713,"eighty":-1.647407,"marketCap":459625350},{"date":"2021-04-01","current":-11.78772,"twenty":-25.399289,"median":-13.536713,"eighty":-1.667605,"marketCap":465555999},{"date":"2021-04-09","current":-11.568407,"twenty":-25.411586,"median":-13.537772,"eighty":-1.683821,"marketCap":456894239},{"date":"2021-04-16","current":-11.470701,"twenty":-25.411586,"median":-13.537772,"eighty":-1.69996,"marketCap":453035335},{"date":"2021-04-23","current":-11.763819,"twenty":-25.411586,"median":-13.537772,"eighty":-1.716245,"marketCap":464612047},{"date":"2021-04-30","current":-11.389385,"twenty":-25.399289,"median":-13.536713,"eighty":-1.728163,"marketCap":499060073},{"date":"2021-05-07","current":-10.516021,"twenty":-25.399289,"median":-13.536713,"eighty":-1.748072,"marketCap":460790991},{"date":"2021-05-14","current":-10.997262,"twenty":-25.399289,"median":-13.536713,"eighty":-1.764364,"marketCap":481878036},{"date":"2021-05-21","current":-10.676434,"twenty":-25.399289,"median":-13.536713,"eighty":-1.780463,"marketCap":467820006},{"date":"2021-05-28","current":-9.339652,"twenty":-25.399289,"median":-13.536713,"eighty":-1.785641,"marketCap":409244880},{"date":"2021-06-04","current":-9.3753,"twenty":-25.399289,"median":-13.536713,"eighty":-1.828278,"marketCap":410806883},{"date":"2021-06-11","current":-10.836848,"twenty":-25.399289,"median":-13.536713,"eighty":-1.8479,"marketCap":474849021},{"date":"2021-06-18","current":-10.943791,"twenty":-25.399289,"median":-13.536713,"eighty":-1.882568,"marketCap":479535031},{"date":"2021-06-25","current":-11.995393,"twenty":-25.399289,"median":-13.536713,"eighty":-1.943791,"marketCap":525614130},{"date":"2021-07-02","current":-11.03291,"twenty":-25.399289,"median":-13.536713,"eighty":-1.966643,"marketCap":483440039},{"date":"2021-07-09","current":-10.997262,"twenty":-25.399289,"median":-13.536713,"eighty":-1.977985,"marketCap":481878036},{"date":"2021-07-16","current":-10.409078,"twenty":-25.399289,"median":-13.536713,"eighty":-2.013559,"marketCap":456104981},{"date":"2021-07-23","current":-10.284312,"twenty":-25.399289,"median":-13.536713,"eighty":-2.028597,"marketCap":450637969},{"date":"2021-07-30","current":-9.689632,"twenty":-25.399289,"median":-13.536713,"eighty":-2.052782,"marketCap":480867356},{"date":"2021-08-06","current":-9.642365,"twenty":-25.399289,"median":-13.536713,"eighty":-2.068819,"marketCap":478521661},{"date":"2021-08-13","current":-9.3115,"twenty":-25.399289,"median":-13.536713,"eighty":-2.079369,"marketCap":462101800},{"date":"2021-08-20","current":-9.138189,"twenty":-25.399289,"median":-13.536713,"eighty":-2.084856,"marketCap":453500921},{"date":"2021-08-27","current":-9.815676,"twenty":-25.399289,"median":-13.536713,"eighty":-2.100894,"marketCap":487122541},{"date":"2021-09-03","current":-10.713739,"twenty":-25.399289,"median":-13.536713,"eighty":-2.116931,"marketCap":531690735},{"date":"2021-09-10","current":-10.398629,"twenty":-25.399289,"median":-13.536713,"eighty":-2.137786,"marketCap":516052772},{"date":"2021-09-17","current":-10.540429,"twenty":-25.399289,"median":-13.536713,"eighty":-2.248379,"marketCap":523089855},{"date":"2021-09-24","current":-10.209563,"twenty":-25.399289,"median":-13.536713,"eighty":-2.477122,"marketCap":506669994},{"date":"2021-10-01","current":-9.673876,"twenty":-25.399289,"median":-13.536713,"eighty":-3.066451,"marketCap":480085457},{"date":"2021-10-08","current":-9.48481,"twenty":-25.386992,"median":-13.535653,"eighty":-3.422547,"marketCap":470702680},{"date":"2021-10-15","current":-9.469055,"twenty":-25.386992,"median":-13.535653,"eighty":-3.746445,"marketCap":469920782},{"date":"2021-10-22","current":-9.075167,"twenty":-25.386992,"median":-13.535653,"eighty":-3.931498,"marketCap":450373328},{"date":"2021-10-29","current":-9.1697,"twenty":-25.386992,"median":-13.535653,"eighty":-4.134737,"marketCap":455064717},{"date":"2021-11-05","current":-9.53443,"twenty":-25.386992,"median":-13.535653,"eighty":-4.513878,"marketCap":510873825},{"date":"2021-11-12","current":-8.979593,"twenty":-25.386992,"median":-13.535653,"eighty":-4.798493,"marketCap":481144567},{"date":"2021-11-19","current":-8.234944,"twenty":-25.386992,"median":-13.535653,"eighty":-4.900663,"marketCap":441244773},{"date":"2021-11-26","current":-7.855319,"twenty":-25.386992,"median":-13.535653,"eighty":-5.011337,"marketCap":420903702},{"date":"2021-12-03","current":-7.169074,"twenty":-25.386992,"median":-13.535653,"eighty":-5.341054,"marketCap":384133304},{"date":"2021-12-10","current":-7.081468,"twenty":-25.386992,"median":-13.535653,"eighty":-7.300482,"marketCap":379439211},{"date":"2021-12-17","current":-7.169074,"twenty":-25.386992,"median":-13.535653,"eighty":-7.300482,"marketCap":384133304},{"date":"2021-12-23","current":-7.5633,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":405256725},{"date":"2021-12-31","current":-6.716444,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":359880489},{"date":"2022-01-07","current":-6.132405,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":328586533},{"date":"2022-01-14","current":-6.190809,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":331715929},{"date":"2022-01-21","current":-5.562968,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":298074927},{"date":"2022-01-28","current":-5.227145,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":280080902},{"date":"2022-02-04","current":-5.183342,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":277733855},{"date":"2022-02-11","current":-5.529152,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":304048067},{"date":"2022-02-18","current":-4.845133,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":266433873},{"date":"2022-02-25","current":-4.887884,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":268784760},{"date":"2022-03-04","current":-4.531625,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":249194034},{"date":"2022-03-11","current":-4.531625,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":249194034},{"date":"2022-03-18","current":-4.802382,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":264082986},{"date":"2022-03-25","current":-4.474623,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":246059518},{"date":"2022-04-01","current":-4.460373,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":245275889},{"date":"2022-04-08","current":-4.132614,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":227252421},{"date":"2022-04-14","current":-3.933108,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":216281615},{"date":"2022-04-22","current":-3.420094,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":188070969},{"date":"2022-04-29","current":-3.225994,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":184149434},{"date":"2022-05-06","current":-3.158221,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":180280748},{"date":"2022-05-13","current":-3.158221,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":180280748},{"date":"2022-05-20","current":-3.090448,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":176412063},{"date":"2022-05-27","current":-3.158221,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":180280748},{"date":"2022-06-03","current":-3.171776,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":181054486},{"date":"2022-06-10","current":-3.022675,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":172543377},{"date":"2022-06-17","current":-3.049785,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":174090852},{"date":"2022-06-24","current":-3.903724,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":222836290},{"date":"2022-07-01","current":-3.822397,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":218193867},{"date":"2022-07-08","current":-4.622118,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":263844357},{"date":"2022-07-15","current":-5.015201,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":286282734},{"date":"2022-07-22","current":-4.581454,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":261523146},{"date":"2022-07-29","current":-3.903546,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":230832318},{"date":"2022-08-05","current":-4.448227,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":263041479},{"date":"2022-08-12","current":-4.876191,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":288348677},{"date":"2022-08-19","current":-4.616819,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":273010981},{"date":"2022-08-26","current":-4.318541,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":255372631},{"date":"2022-09-02","current":-4.111044,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":243102475},{"date":"2022-09-09","current":-4.085107,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":241568705},{"date":"2022-09-16","current":-4.188856,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":247703783},{"date":"2022-09-23","current":-3.449646,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":203991351},{"date":"2022-09-30","current":-3.527457,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":208592660},{"date":"2022-10-07","current":-3.721986,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":220095931},{"date":"2022-10-14","current":-4.24073,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":250771323},{"date":"2022-10-21","current":-5.317123,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":314422759},{"date":"2022-10-28","current":-5.173587,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":319024068},{"date":"2022-11-04","current":-5.273079,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":325159146},{"date":"2022-11-11","current":-5.19846,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":320557838},{"date":"2022-11-18","current":-4.974603,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":306753912},{"date":"2022-11-25","current":-4.987039,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":307520796},{"date":"2022-12-02","current":-5.297952,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":326692916},{"date":"2022-12-09","current":-4.576635,"twenty":-25.386992,"median":-13.535653,"eighty":-7.244999,"marketCap":282213599},{"date":"2022-12-16","current":-4.999476,"twenty":-25.386992,"median":-13.535653,"eighty":-7.119431,"marketCap":308287681},{"date":"2022-12-23","current":-10.508849,"twenty":-25.386992,"median":-13.535653,"eighty":-7.119431,"marketCap":648017639},{"date":"2022-12-30","current":-11.690317,"twenty":-25.386992,"median":-13.535653,"eighty":-7.119431,"marketCap":720871693},{"date":"2023-01-06","current":-10.496412,"twenty":-25.386992,"median":-13.535653,"eighty":-7.119431,"marketCap":647250754},{"date":"2023-01-13","current":-11.130674,"twenty":-25.386992,"median":-13.535653,"eighty":-7.119431,"marketCap":686361878},{"date":"2023-01-20","current":-10.794888,"twenty":-25.386992,"median":-13.535653,"eighty":-7.119431,"marketCap":665655989},{"date":"2023-01-27","current":-10.658087,"twenty":-25.386992,"median":-13.535653,"eighty":-7.119431,"marketCap":657220256},{"date":"2023-02-03","current":-11.317222,"twenty":-25.386992,"median":-13.524439,"eighty":-7.119431,"marketCap":697865149},{"date":"2023-02-10","current":-12.149879,"twenty":-25.386992,"median":-13.434725,"eighty":-7.119431,"marketCap":836725704},{"date":"2023-02-17","current":-12.85587,"twenty":-25.386992,"median":-13.334708,"eighty":-7.119431,"marketCap":885345192},{"date":"2023-02-24","current":-12.525648,"twenty":-25.386992,"median":-13.255296,"eighty":-7.119431,"marketCap":862603819},{"date":"2023-03-03","current":-13.470765,"twenty":-25.386992,"median":-13.213514,"eighty":-7.119431,"marketCap":927691198},{"date":"2023-03-10","current":-11.785496,"twenty":-25.386992,"median":-13.158792,"eighty":-7.119431,"marketCap":811631775},{"date":"2023-03-17","current":-13.470765,"twenty":-25.386992,"median":-13.120724,"eighty":-7.119431,"marketCap":927691198},{"date":"2023-03-24","current":-10.077453,"twenty":-25.386992,"median":-13.112183,"eighty":-7.119431,"marketCap":694003981},{"date":"2023-03-31","current":-23.127881,"twenty":-25.374695,"median":-13.132194,"eighty":-7.122351,"marketCap":1592747807},{"date":"2023-04-06","current":-27.368372,"twenty":-25.498525,"median":-13.200762,"eighty":-7.122351,"marketCap":1884777689},{"date":"2023-04-14","current":-31.225434,"twenty":-25.600181,"median":-13.255296,"eighty":-7.119431,"marketCap":2150401995},{"date":"2023-04-21","current":-29.188583,"twenty":-25.700564,"median":-13.388585,"eighty":-7.119431,"marketCap":2010130121},{"date":"2023-04-28","current":-26.649427,"twenty":-25.824845,"median":-13.470765,"eighty":-7.119431,"marketCap":1926620316},{"date":"2023-05-05","current":-29.92626,"twenty":-25.971096,"median":-13.535653,"eighty":-7.119431,"marketCap":2163518996},{"date":"2023-05-12","current":-31.6387,"twenty":-26.182902,"median":-13.578304,"eighty":-7.119431,"marketCap":2287319806},{"date":"2023-05-19","current":-32.01157,"twenty":-26.537926,"median":-13.59857,"eighty":-7.119431,"marketCap":2314276434},{"date":"2023-05-26","current":-28.862891,"twenty":-26.646108,"median":-13.636582,"eighty":-7.119431,"marketCap":2086642686},{"date":"2023-06-02","current":-30.34056,"twenty":-26.780985,"median":-13.659011,"eighty":-7.119431,"marketCap":2193470805},{"date":"2023-06-09","current":-34.234979,"twenty":-26.930727,"median":-13.659011,"eighty":-7.119431,"marketCap":2475017808},{"date":"2023-06-16","current":-31.01725,"twenty":-26.930727,"median":-13.659011,"eighty":-7.119431,"marketCap":2242392092},{"date":"2023-06-23","current":-30.10579,"twenty":-26.891574,"median":-13.647797,"eighty":-7.11651,"marketCap":2176498113},{"date":"2023-06-30","current":-21.571213,"twenty":-26.72914,"median":-13.636582,"eighty":-7.11359,"marketCap":1559490850},{"date":"2023-07-07","current":-22.082183,"twenty":-26.566581,"median":-13.636582,"eighty":-7.11359,"marketCap":1596431414},{"date":"2023-07-14","current":-21.736933,"twenty":-26.246081,"median":-13.636582,"eighty":-7.11359,"marketCap":1571471573},{"date":"2023-07-21","current":-20.991193,"twenty":-26.032581,"median":-13.636582,"eighty":-7.11359,"marketCap":1517558317},{"date":"2023-07-28","current":-18.510356,"twenty":-25.900267,"median":-13.636582,"eighty":-7.11359,"marketCap":1371395231},{"date":"2023-08-04","current":-18.226827,"twenty":-25.725158,"median":-13.636582,"eighty":-7.11359,"marketCap":1350389178},{"date":"2023-08-11","current":-20.090014,"twenty":-25.632931,"median":-13.636582,"eighty":-7.11359,"marketCap":1488428960},{"date":"2023-08-18","current":-19.090914,"twenty":-25.535318,"median":-13.636582,"eighty":-7.11359,"marketCap":1414407627},{"date":"2023-08-25","current":-18.348339,"twenty":-25.35625,"median":-13.636582,"eighty":-7.11359,"marketCap":1359391772},{"date":"2023-09-01","current":-18.645369,"twenty":-25.270172,"median":-13.636582,"eighty":-7.11359,"marketCap":1381398114},{"date":"2023-09-08","current":-19.725477,"twenty":-25.104163,"median":-13.636582,"eighty":-7.11359,"marketCap":1461421177},{"date":"2023-09-15","current":-20.25203,"twenty":-24.980609,"median":-13.636582,"eighty":-7.11359,"marketCap":1500432420},{"date":"2023-09-22","current":-17.970302,"twenty":-24.737721,"median":-13.636582,"eighty":-7.11359,"marketCap":1331383700},{"date":"2023-09-29","current":-15.148519,"twenty":-24.618435,"median":-13.636582,"eighty":-7.11359,"marketCap":1122323450},{"date":"2023-10-06","current":-15.067511,"twenty":-24.500824,"median":-13.636582,"eighty":-7.11359,"marketCap":1116321720},{"date":"2023-10-13","current":-14.973001,"twenty":-24.433267,"median":-13.636582,"eighty":-7.11359,"marketCap":1109319702},{"date":"2023-10-20","current":-13.636367,"twenty":-24.347195,"median":-13.636367,"eighty":-7.11359,"marketCap":1010291162},{"date":"2023-10-27","current":-11.957845,"twenty":-24.235304,"median":-13.588437,"eighty":-7.10483,"marketCap":966779830},{"date":"2023-11-03","current":-12.100127,"twenty":-24.100234,"median":-13.537772,"eighty":-7.10483,"marketCap":978283160},{"date":"2023-11-10","current":-11.753702,"twenty":-23.899065,"median":-13.487141,"eighty":-7.10483,"marketCap":950275053},{"date":"2023-11-17","current":-13.028051,"twenty":-23.701223,"median":-13.463736,"eighty":-7.10483,"marketCap":1053304875},{"date":"2023-11-24","current":-15.193206,"twenty":-23.64083,"median":-13.463736,"eighty":-7.10483,"marketCap":1228355542},{"date":"2023-12-01","current":-15.118972,"twenty":-23.382093,"median":-13.463736,"eighty":-7.10483,"marketCap":1222353805},{"date":"2023-12-08","current":-22.319661,"twenty":-23.156555,"median":-13.470765,"eighty":-7.10775,"marketCap":1804522312},{"date":"2023-12-15","current":-23.779595,"twenty":-22.865343,"median":-13.470765,"eighty":-7.10775,"marketCap":1922556476},{"date":"2023-12-22","current":-22.282545,"twenty":-22.81441,"median":-13.470765,"eighty":-7.10775,"marketCap":1801521443},{"date":"2023-12-29","current":-23.841457,"twenty":-22.774551,"median":-13.463736,"eighty":-7.10483,"marketCap":1927557924},{"date":"2024-01-05","current":-22.987767,"twenty":-22.665451,"median":-13.456707,"eighty":-7.101909,"marketCap":1858537946},{"date":"2024-01-12","current":-26.018985,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":2103608881},{"date":"2024-01-19","current":-25.907634,"twenty":-22.612622,"median":-13.445716,"eighty":-7.098989,"marketCap":2094606275},{"date":"2024-01-26","current":-26.612856,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":2151622779},{"date":"2024-02-02","current":-29.631701,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":2395693424},{"date":"2024-02-09","current":-33.798336,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":2903108113},{"date":"2024-02-16","current":-37.261233,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":3200553597},{"date":"2024-02-23","current":-41.718542,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":3583414168},{"date":"2024-03-01","current":-97.224678,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":8351113716},{"date":"2024-03-08","current":-94.212301,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":8092365608},{"date":"2024-03-15","current":-82.817705,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":7113626794},{"date":"2024-03-22","current":-89.870896,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":7719460652},{"date":"2024-03-28","current":-106.103421,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":9113753375},{"date":"2024-04-05","current":-93.804897,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":8057371594},{"date":"2024-04-12","current":-90.938346,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":7811149234},{"date":"2024-04-19","current":-82.982684,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":7127797671},{"date":"2024-04-26","current":-81.018661,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":7593068940},{"date":"2024-05-03","current":-89.136999,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":8353919589},{"date":"2024-05-10","current":-94.360974,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":8843510442},{"date":"2024-05-17","current":-81.253975,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":7615122582},{"date":"2024-05-24","current":-72.441461,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":6789213689},{"date":"2024-05-31","current":-72.68854,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":6812370013},{"date":"2024-06-07","current":-64.723157,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":6065854232},{"date":"2024-06-14","current":-61.299336,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":5744973741},{"date":"2024-06-21","current":-59.334463,"twenty":-22.612622,"median":-13.445716,"eighty":-7.098989,"marketCap":5560825830},{"date":"2024-06-28","current":-59.734497,"twenty":-22.547664,"median":-13.342177,"eighty":-7.096069,"marketCap":5598317021},{"date":"2024-07-05","current":-59.381525,"twenty":-22.547664,"median":-13.342177,"eighty":-7.096069,"marketCap":5565236558},{"date":"2024-07-12","current":-68.982343,"twenty":-22.547664,"median":-13.342177,"eighty":-7.096069,"marketCap":6465025152},{"date":"2024-07-15","current":-67.276315,"twenty":-22.547664,"median":-13.342177,"eighty":-7.096069,"marketCap":6305136247},{"date":"2024-08-02","current":-62.587341,"twenty":-22.095993,"median":-13.232948,"eighty":-7.052266,"marketCap":6055012330},{"date":"2024-08-09","current":-63.87001,"twenty":-22.443419,"median":-13.232948,"eighty":-7.052266,"marketCap":6179104074},{"date":"2024-08-16","current":-65.278654,"twenty":-22.56606,"median":-13.232948,"eighty":-7.052266,"marketCap":6315383400},{"date":"2024-08-23","current":-73.696165,"twenty":-22.69325,"median":-13.232948,"eighty":-7.052266,"marketCap":7129735470},{"date":"2024-08-30","current":-71.749258,"twenty":-22.870541,"median":-13.232948,"eighty":-7.052266,"marketCap":6941381930},{"date":"2024-09-06","current":-63.434819,"twenty":-23.27125,"median":-13.232948,"eighty":-7.052266,"marketCap":6137001518},{"date":"2024-09-13","current":-71.932496,"twenty":-23.507404,"median":-13.232948,"eighty":-7.052266,"marketCap":6959109322},{"date":"2024-09-20","current":-78.059528,"twenty":-23.680616,"median":-13.232948,"eighty":-7.052266,"marketCap":7551868992},{"date":"2024-09-27","current":-71.371329,"twenty":-23.823137,"median":-13.232948,"eighty":-7.052266,"marketCap":6904819184},{"date":"2024-10-04","current":-73.421307,"twenty":-24.072444,"median":-13.232948,"eighty":-7.052266,"marketCap":7103144382},{"date":"2024-10-11","current":-71.52021,"twenty":-24.313704,"median":-13.232948,"eighty":-7.052266,"marketCap":6919222690},{"date":"2024-10-18","current":-73.999653,"twenty":-24.497666,"median":-13.232948,"eighty":-7.052266,"marketCap":7159096463},{"date":"2024-10-25","current":-82.292383,"twenty":-24.926912,"median":-13.232948,"eighty":-7.052266,"marketCap":8159372036},{"date":"2024-10-31","current":-80.640241,"twenty":-25.54012,"median":-13.232948,"eighty":-7.052266,"marketCap":7995560552},{"date":"2024-11-08","current":-77.380914,"twenty":-26.452015,"median":-13.232867,"eighty":-7.025984,"marketCap":7672395038},{"date":"2024-11-15","current":-60.207634,"twenty":-26.619064,"median":-13.232867,"eighty":-7.025984,"marketCap":5969647090},{"date":"2024-11-22","current":-58.027256,"twenty":-26.775391,"median":-13.232867,"eighty":-7.025984,"marketCap":5753460505},{"date":"2024-11-29","current":-59.499573,"twenty":-27.978567,"median":-13.232867,"eighty":-7.025984,"marketCap":5899442168},{"date":"2024-12-06","current":-56.060421,"twenty":-28.427248,"median":-13.232867,"eighty":-7.025984,"marketCap":5558446833},{"date":"2024-12-13","current":-53.801371,"twenty":-28.890511,"median":-13.232867,"eighty":-7.025984,"marketCap":5334459702},{"date":"2024-12-20","current":-46.630852,"twenty":-29.221496,"median":-13.232867,"eighty":-7.025984,"marketCap":4623495572},{"date":"2024-12-27","current":-47.9683,"twenty":-29.590258,"median":-13.232867,"eighty":-7.025984,"marketCap":4756104869},{"date":"2025-01-03","current":-46.215007,"twenty":-29.679256,"median":-13.232867,"eighty":-7.025984,"marketCap":4582264110},{"date":"2025-01-10","current":-45.630575,"twenty":-30.111314,"median":-13.223191,"eighty":-6.999702,"marketCap":4524317190},{"date":"2025-01-17","current":-36.594373,"twenty":-30.341993,"median":-13.223191,"eighty":-6.999702,"marketCap":3628368663},{"date":"2025-01-24","current":-39.269269,"twenty":-30.456513,"median":-13.223191,"eighty":-6.999702,"marketCap":3893587256},{"date":"2025-01-31","current":-37.864386,"twenty":-31.008964,"median":-13.223191,"eighty":-6.999702,"marketCap":3754291776},{"date":"2025-02-07","current":-31.920763,"twenty":-31.503362,"median":-13.223191,"eighty":-6.999702,"marketCap":3510102907},{"date":"2025-02-14","current":-29.932057,"twenty":-31.56965,"median":-13.223191,"eighty":-6.999702,"marketCap":3291418810},{"date":"2025-02-21","current":-32.093253,"twenty":-31.671844,"median":-13.223191,"eighty":-6.999702,"marketCap":3529070405},{"date":"2025-02-28","current":-29.089901,"twenty":-31.7768,"median":-13.223191,"eighty":-6.999702,"marketCap":3198812789},{"date":"2025-03-07","current":-29.275912,"twenty":-31.80442,"median":-13.213514,"eighty":-6.973421,"marketCap":3219267162},{"date":"2025-03-14","current":-30.347729,"twenty":-31.80442,"median":-13.23303,"eighty":-6.973421,"marketCap":3337127361},{"date":"2025-03-21","current":-28.939056,"twenty":-31.80442,"median":-13.308111,"eighty":-6.973421,"marketCap":3182225385},{"date":"2025-03-28","current":-26.672929,"twenty":-31.80442,"median":-13.470765,"eighty":-6.973421,"marketCap":2933035249},{"date":"2025-04-04","current":-24.723243,"twenty":-31.80442,"median":-13.524439,"eighty":-6.973421,"marketCap":2718641933},{"date":"2025-04-11","current":-21.967142,"twenty":-31.7768,"median":-13.537772,"eighty":-6.999702,"marketCap":2415572849},{"date":"2025-04-17","current":-24.09036,"twenty":-31.7768,"median":-13.537772,"eighty":-6.999702,"marketCap":2649048292},{"date":"2025-04-21","current":-24.437425,"twenty":-31.80442,"median":-13.537772,"eighty":-6.973421,"marketCap":2687212547}],"updateTime":1745321472920}}}